4
Changes in Ownership
Lyell Immunopharma, Inc. Filed Acc 0001415889-25-005753
Chief Financial Officer acquired 112,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Newton Charles W. · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-10 | Grant or award : show line 1 in the form | +112,500 | 172,725 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-10 | Grant or award : show line 2 in the form Option (right to buy) | +450,000 | 450,000 | D |
| 2025-02-10 | Grant or award : show line 3 in the form Option (right to buy) | +56,250 | 56,250 | D |
Loading xslF345X05/form4-02272025_120230.xml…